JP2019536810A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536810A5
JP2019536810A5 JP2019530725A JP2019530725A JP2019536810A5 JP 2019536810 A5 JP2019536810 A5 JP 2019536810A5 JP 2019530725 A JP2019530725 A JP 2019530725A JP 2019530725 A JP2019530725 A JP 2019530725A JP 2019536810 A5 JP2019536810 A5 JP 2019536810A5
Authority
JP
Japan
Prior art keywords
benzenesulfonamide
amino
thiazol
fluoro
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019530725A
Other languages
English (en)
Japanese (ja)
Other versions
JP7022751B2 (ja
JP2019536810A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/033666 external-priority patent/WO2018106284A1/en
Publication of JP2019536810A publication Critical patent/JP2019536810A/ja
Publication of JP2019536810A5 publication Critical patent/JP2019536810A5/ja
Application granted granted Critical
Publication of JP7022751B2 publication Critical patent/JP7022751B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019530725A 2016-12-09 2017-05-19 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用 Active JP7022751B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662432169P 2016-12-09 2016-12-09
US62/432,169 2016-12-09
PCT/US2017/033666 WO2018106284A1 (en) 2016-12-09 2017-05-19 Benzenesulfonamide compounds and their use as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2019536810A JP2019536810A (ja) 2019-12-19
JP2019536810A5 true JP2019536810A5 (cg-RX-API-DMAC7.html) 2020-06-25
JP7022751B2 JP7022751B2 (ja) 2022-02-18

Family

ID=62488471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019530725A Active JP7022751B2 (ja) 2016-12-09 2017-05-19 ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用

Country Status (18)

Country Link
US (2) US20180162868A1 (cg-RX-API-DMAC7.html)
EP (1) EP3551626B1 (cg-RX-API-DMAC7.html)
JP (1) JP7022751B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190086772A (cg-RX-API-DMAC7.html)
CN (1) CN110325531B (cg-RX-API-DMAC7.html)
AU (1) AU2017371674B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019011121A2 (cg-RX-API-DMAC7.html)
CL (1) CL2019001481A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019005552A2 (cg-RX-API-DMAC7.html)
ES (1) ES2967410T3 (cg-RX-API-DMAC7.html)
IL (1) IL267143A (cg-RX-API-DMAC7.html)
MA (1) MA48583A (cg-RX-API-DMAC7.html)
MX (1) MX2019006697A (cg-RX-API-DMAC7.html)
PH (1) PH12019501074A1 (cg-RX-API-DMAC7.html)
RU (1) RU2760303C2 (cg-RX-API-DMAC7.html)
SG (2) SG10201912376VA (cg-RX-API-DMAC7.html)
TN (1) TN2019000175A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018106284A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017201468A1 (en) 2016-05-20 2017-11-23 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
EP3551626B1 (en) 2016-12-09 2023-10-25 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
AU2019285184B2 (en) 2018-06-13 2023-11-16 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
US10981905B2 (en) * 2018-08-31 2021-04-20 Xenon Pharmaceuticals Inc. Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
MA53488A (fr) * 2018-08-31 2021-12-08 Xenon Pharmaceuticals Inc Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
CN111285825B (zh) * 2018-12-10 2023-02-17 中国科学院上海药物研究所 一类苯磺酰胺取代的衍生物,其制法及其用途
JP2023503343A (ja) 2019-11-26 2023-01-27 プラクシス プレシジョン メディシンズ, インコーポレイテッド イオンチャネルモジュレーター
CN112125838B (zh) * 2020-08-31 2021-07-27 浙江工业大学 一种三氟甲基化苯胺类化合物及其应用
WO2023028056A1 (en) 2021-08-24 2023-03-02 Genentech, Inc. 3-amino piperidyl sodium channel inhibitors
CN113698357A (zh) * 2021-09-29 2021-11-26 守恒(厦门)医疗科技有限公司 磺胺嘧啶类衍生物及其在抗肿瘤药物的应用
CN113861130A (zh) * 2021-09-29 2021-12-31 守恒(厦门)医疗科技有限公司 联苯磺胺噻二唑类衍生物及其在抗肿瘤药物的应用
AR133184A1 (es) * 2023-07-07 2025-09-03 Novartis Ag Bloqueadores de canales de sodio

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5877193A (en) 1996-07-19 1999-03-02 Hoffmann-La Roche Inc. Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
AU741482B2 (en) 1997-05-07 2001-11-29 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
CA2349832A1 (en) 1999-01-13 2000-07-20 Warner-Lambert Company Benzenesulfonamide derivatives and their use as mek inhibitors
ATE250932T1 (de) 1999-07-16 2003-10-15 Warner Lambert Co Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
FR2836917B1 (fr) 2002-03-11 2006-02-24 Lipha Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
CA2744893A1 (en) 2002-06-27 2004-01-08 Novo Nordisk A/S Aryl carbonyl derivatives as glucokinase activators
WO2004092123A2 (en) * 2003-04-10 2004-10-28 Microbia, Inc. Inhibitors of fungal invasion
WO2005000309A2 (en) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Chemical compounds
CA2531418A1 (en) 2003-07-08 2005-01-20 Novartis Ag Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
KR20060073930A (ko) 2003-08-08 2006-06-29 버텍스 파마슈티칼스 인코포레이티드 통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
WO2006066109A2 (en) * 2004-12-17 2006-06-22 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
GB0510139D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
WO2007039171A1 (en) 2005-10-06 2007-04-12 Sanofi-Aventis 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
WO2007075895A2 (en) 2005-12-21 2007-07-05 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
KR101117931B1 (ko) 2006-08-15 2012-04-12 에프. 호프만-라 로슈 아게 페닐, 피리딘 및 퀴놀린 유도체
RU2474582C2 (ru) 2006-10-19 2013-02-10 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Гетероарильные соединения, их композиции и их применение в качестве ингибиторов протеинкиназы
JP5460589B2 (ja) * 2007-07-13 2014-04-02 アイカジェン, インコーポレイテッド ナトリウムチャネル阻害物質
US8853250B2 (en) * 2007-07-13 2014-10-07 Icagen, Inc. Sodium channel inhibitors
WO2009013171A2 (en) 2007-07-24 2009-01-29 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
NZ588983A (en) 2008-06-25 2011-11-25 Daiichi Sankyo Co Ltd Carboxylic acid compound
EP2307412A2 (en) 2008-07-01 2011-04-13 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
US20110294853A1 (en) 2008-09-12 2011-12-01 Benjamin Pelcman Bis Aromatic Compounds for Use in the Treatment of Inflammation
CA2747419C (en) * 2009-01-12 2014-07-08 Icagen, Inc. Sulfonamide derivatives
WO2012004743A1 (en) 2010-07-09 2012-01-12 Pfizer Limited Benzenesulfonamides useful as sodium channel inhibitors
BR112013003864B1 (pt) 2010-08-20 2021-08-31 Hutchison Medipharma Limited Compostos de pirrolpirimidina, composição e uso dos mesmos
AU2012296529A1 (en) 2011-08-17 2014-02-20 Amgen Inc. Heteroaryl sodium channel inhibitors
AU2012328561A1 (en) 2011-10-28 2014-04-17 Merck Sharp & Dohme Corp. Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
ES2586213T3 (es) * 2011-10-31 2016-10-13 Xenon Pharmaceuticals Inc. Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
MX2014005304A (es) * 2011-10-31 2015-03-20 Xenon Pharmaceuticals Inc Biaril eter sulfonamidas y su uso como agentes terapeuticos.
US8889741B2 (en) * 2012-02-09 2014-11-18 Daiichi Sankyo Company, Limited Cycloalkane derivatives
WO2013122897A1 (en) 2012-02-13 2013-08-22 Amgen Inc. Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
CA2874621A1 (en) 2012-05-22 2013-11-28 Genentech, Inc. N-substituted benzamides and their use in the treatment of pain
US9376429B2 (en) * 2012-10-15 2016-06-28 Daewoong Pharmaceutical Co., Ltd. Sodium channel blockers, preparation method thereof and use thereof
JP2015535251A (ja) 2012-10-26 2015-12-10 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 電位作動型ナトリウムチャネルにおいて選択的活性を有するベンゾオキサゾリノン化合物
AU2013334664A1 (en) 2012-10-26 2015-05-07 Merck Sharp & Dohme Corp. N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
TW201443025A (zh) * 2013-04-19 2014-11-16 Pfizer Ltd 化學化合物
TW201512171A (zh) * 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物
US9212182B2 (en) 2013-06-12 2015-12-15 Amgen Inc. Bicyclic sulfonamide compounds as sodium channel inhibitors
GB201310542D0 (en) 2013-06-13 2013-07-31 Antabio Sas Compounds
WO2015035278A1 (en) 2013-09-09 2015-03-12 Bristol-Myers Squibb Company RORγ MODULATORS
CN105611923B (zh) 2013-09-10 2019-08-23 卓莫赛尔公司 用于治疗疼痛和糖尿病的钠通道调节剂
JP6383418B2 (ja) 2013-11-27 2018-08-29 ジェネンテック, インコーポレイテッド 置換ベンズアミド及びその使用方法
WO2015077905A1 (en) 2013-11-29 2015-06-04 Merck Sharp & Dohme Corp. Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
CA2934473C (en) * 2013-12-23 2019-08-20 Purdue Pharma L.P. Indazoles and use thereof
CN106795149B (zh) * 2015-05-05 2019-09-24 上海海雁医药科技有限公司 双环取代的苯磺酰胺衍生物、其制法与医药上的用途
BR112018012408A2 (pt) 2015-12-18 2018-12-04 Merck Sharp & Dohme ?composto, composição, e, método para tratar um distúrbio de dor ou distúrbio de tosse ou de coceira aguda ou de coceira crônica?
US10442778B2 (en) * 2016-03-22 2019-10-15 Merck Sharp & Dohme Corp. N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels
WO2017201468A1 (en) 2016-05-20 2017-11-23 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
ES2897998T3 (es) * 2016-10-27 2022-03-03 Bristol Myers Squibb Co Inhibidores de la acilsulfonamida del NaV1.7
US10968210B2 (en) * 2016-11-17 2021-04-06 Merck Sharp & Dohme Corp. Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
EP3551626B1 (en) 2016-12-09 2023-10-25 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
AU2019285184B2 (en) 2018-06-13 2023-11-16 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
MA53488A (fr) 2018-08-31 2021-12-08 Xenon Pharmaceuticals Inc Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
US10981905B2 (en) 2018-08-31 2021-04-20 Xenon Pharmaceuticals Inc. Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

Similar Documents

Publication Publication Date Title
RU2019120812A (ru) Соединения бензолсульфонамидов и их использование в качестве терапевтических средств
RU2200158C2 (ru) Замещенные изоксазолы, фармацевтические композиции на их основе и способ подавления воспалений
ES2536191T3 (es) Derivados de sulfonamida
JP2004502670A5 (cg-RX-API-DMAC7.html)
JP2021515033A5 (cg-RX-API-DMAC7.html)
RU2419624C2 (ru) Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2
JP2010533158A5 (cg-RX-API-DMAC7.html)
JP2021524484A5 (cg-RX-API-DMAC7.html)
CN113227071A (zh) 治疗与IL-12、IL-23和/或IFN-α的调节相关的病症的酰胺取代的杂环化合物
JP2008501673A5 (cg-RX-API-DMAC7.html)
RU2017133983A (ru) Бициклические тетрагидротиазепиновые производные, полезные для лечения неопластических и/или инфекционных заболеваний
JP2005513026A5 (cg-RX-API-DMAC7.html)
JP2010540452A5 (cg-RX-API-DMAC7.html)
JP2016503009A5 (cg-RX-API-DMAC7.html)
RU2014121984A (ru) Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
CA2439415A1 (en) Cathepsin cysteine protease inhibitors
RU2010125624A (ru) Новые циклические углеводородные соединения для лечения заболеваний
JP2023536164A5 (cg-RX-API-DMAC7.html)
HRP20200575T1 (hr) Spojevi karbamata i postupci pripremanja i korištenja istih
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
NZ724602A (en) Ror-gamma modulators and uses thereof
JP2021501179A5 (cg-RX-API-DMAC7.html)
JP2022536773A5 (cg-RX-API-DMAC7.html)
IL269710B2 (en) 2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in cancer therapy
JP2020516659A5 (cg-RX-API-DMAC7.html)